No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients

被引:17
|
作者
Schippers, EF
Hugen, PWH
den Hartigh, J
Burger, DM
Hoetelmans, RMW
Visser, LG
Kroon, FP
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Pharm & Toxicol, NL-2300 RC Leiden, Netherlands
[3] Univ Nijmegen, Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[4] Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands
关键词
D O I
10.1097/00002030-200012010-00023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:2794 / 2795
页数:2
相关论文
共 50 条
  • [21] Indinavir plasma protein binding in HIV-1-infected adults
    Anderson, PL
    Brundage, RC
    Bushman, L
    Kakuda, TN
    Remmel, RP
    Fletcher, CV
    AIDS, 2000, 14 (15) : 2293 - 2297
  • [22] Potential Drug-Drug Interaction between Orthopedics Drug Carprofen and HIV Treatment Drug Zidovudine (AZT)
    Lin, Jiang-Tao
    Ge, Jun-Bo
    LATIN AMERICAN JOURNAL OF PHARMACY, 2014, 33 (09): : 1571 - 1573
  • [23] PAH Therapy In HIV: Lack Of Drug-Drug Interaction Between Ambrisentan And Ritonavir
    Gillies, H. C.
    Wang, X.
    Staehr, P.
    Zack, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [24] Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretrovirals
    Rusconi, S
    Argenteri, B
    Galli, M
    d'Arminio-Monforte, A
    Moroni, M
    ANTIVIRAL THERAPY, 1999, 4 (03) : 183 - 184
  • [25] Prevalence of HIV-1 drug resistance in HIV-1-infected patients treated in Douala, Cameroon
    Charpentier, C.
    Talla, F.
    Joko, A.
    Si-Mohamed, A.
    Belec, L.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A191 - A191
  • [26] Management of a drug-drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma
    Lagoutte-Renosi, Jennifer
    Karsenty, Judith
    Martha, Benoit
    Davani, Siamak
    Muret, Patrice
    AIDS, 2023, 37 (07) : 1181 - 1183
  • [27] Oxidative stress in HIV-1-infected injection drug users
    Tang, AM
    Smit, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 : S12 - S18
  • [28] Therapeutic drug monitoring of indinavir, boosted with ritonavir, in HIV infected pediatric patients
    Caceres, P. G.
    Curras, G.
    Bramuglia, G.
    Hocht, Ch.
    Rubio, M.
    Mecicovsky, D.
    Bologna, R.
    Bedrinana, S.
    Mato, G.
    PEDIATRIC RESEARCH, 2006, 60 (05) : 636 - 636
  • [29] Therapeutic drug monitoring of indinavir in HIV-Infected patients undergoing HAART
    Langmann, R
    Zilly, M
    Weissbrich, B
    Desch, S
    Väth, T
    Klinker, H
    INFECTION, 2002, 30 (01) : 13 - 16
  • [30] The challenge of antiretroviral drug resistance in HIV-1-infected children
    Shafer, Robert W.
    JORNAL DE PEDIATRIA, 2009, 85 (02) : 91 - 94